SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-069494
Filing Date
2023-08-21
Accepted
2023-08-21 17:10:08
Documents
12
Period of Report
2023-08-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183965-8k_hoththera.htm   iXBRL 8-K 35593
  Complete submission text file 0001213900-23-069494.txt   211308

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hoth-20230818.xsd EX-101.SCH 3039
3 XBRL LABEL FILE hoth-20230818_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hoth-20230818_pre.xml EX-101.PRE 22375
6 EXTRACTED XBRL INSTANCE DOCUMENT ea183965-8k_hoththera_htm.xml XML 3406
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 231189946
SIC: 2834 Pharmaceutical Preparations